Catalyst Pharmaceuticals, Inc. (CPRX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$23.99
Day's range
$24.89

Catalyst Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 18.77 M $464.86 M   0.79% 15.35%
STATE STREET CORP 05/15/2026 6.86 M $169.93 M   -0.65% 5.61%
05/15/2026 5.12 M $126.84 M   100.00% 4.19%
AMERICAN CENTURY COMPANIES INC 05/15/2026 4.14 M $102.47 M   36.79% 3.38%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 05/15/2026 3.94 M $97.64 M   -19.70% 3.22%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 3.43 M $84.91 M   14.46% 2.80%
BANK OF AMERICA CORP /DE/ 05/18/2026 3.04 M $75.18 M   38.03% 2.48%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.97 M $73.61 M   2.48% 2.43%
MORGAN STANLEY 05/15/2026 2.69 M $66.54 M   -8.39% 2.20%
05/08/2026 2.48 M $61.29 M   100.00% 2.02%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 2.35 M $58.12 M   -11.42% 1.92%
ROYCE & ASSOCIATES LP 05/12/2026 2.09 M $51.75 M   9.38% 1.71%
JANUS HENDERSON GROUP PLC 05/18/2026 2.00 M $49.52 M   16.23% 1.63%
BOSTON PARTNERS 05/11/2026 1.71 M $42.45 M   39.00% 1.40%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 1.43 M $35.40 M   5.41% 1.17%
NORTHERN TRUST CORP 05/14/2026 1.24 M $30.65 M   2.13% 1.01%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2026 1.20 M $29.70 M   -0.83% 0.98%
UBS GROUP AG 05/05/2026 986.09 K $24.42 M   51.94% 0.81%
GOLDMAN SACHS GROUP INC 05/15/2026 984.73 K $24.38 M   0.53% 0.81%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 05/14/2026 955.32 K $23.65 M   -40.93% 0.78%
RAYMOND JAMES FINANCIAL INC 05/14/2026 889.94 K $21.56 M   5.70% 0.73%
VICTORY CAPITAL MANAGEMENT INC 05/15/2026 866.62 K $21.46 M   -2.03% 0.71%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 852.82 K $21.12 M   419.34% 0.70%
FUNDSMITH LLP 05/15/2026 844.89 K $20.92 M   -74.88% 0.69%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 802.63 K $19.87 M   100.00% 0.66%
OBERWEIS ASSET MANAGEMENT INC/ 05/15/2026 780.57 K $19.33 M   32.98% 0.64%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 773.45 K $19.15 M   3.29% 0.63%
MILLENNIUM MANAGEMENT LLC 05/15/2026 766.99 K $18.99 M   -22.81% 0.63%
INVESCO LTD. 05/12/2026 752.84 K $18.64 M   -41.80% 0.62%
MACQUARIE MANAGEMENT HOLDINGS, INC. 05/15/2026 748.10 K $18.52 M   -3.92% 0.61%
SYSTEMATIC FINANCIAL MANAGEMENT LP 05/13/2026 747.52 K $18.51 M   3.36% 0.61%
FEDERATED HERMES, INC. 05/11/2026 740.30 K $18.33 M   11.53% 0.61%
BANK OF NEW YORK MELLON CORP 05/05/2026 682.29 K $16.89 M   -2.62% 0.56%
PRINCIPAL FINANCIAL GROUP INC 05/04/2026 675.98 K $16.74 M   -1.13% 0.55%
SWEDBANK AB 04/29/2026 616.13 K $15.26 M   0.00% 0.50%
LSV ASSET MANAGEMENT 05/11/2026 609.50 K $15.09 M   12.89% 0.50%
VOYA INVESTMENT MANAGEMENT LLC 05/12/2026 589.88 K $14.61 M   3.95% 0.48%
CITADEL ADVISORS LLC 05/15/2026 581.09 K $14.39 M   88.38% 0.48%
CLARK CAPITAL MANAGEMENT GROUP, INC. 05/15/2026 568.68 K $14.08 M   100.00% 0.47%
GLENMEDE TRUST CO NA 05/26/2026 565.42 K $14.00 M   -8.54% 0.46%
IMC-CHICAGO, LLC 05/05/2026 563.67 K $13.96 M   100.00% 0.46%
JANE STREET GROUP, LLC 05/12/2026 545.23 K $13.50 M   104.78% 0.45%
PUBLIC SECTOR PENSION INVESTMENT BOARD 05/13/2026 526.35 K $13.03 M   6.78% 0.43%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 05/08/2026 479.04 K $11.86 M   100.00% 0.39%
JPMORGAN CHASE & CO 05/13/2026 466.82 K $11.10 M   26.22% 0.38%
GLOBEFLEX CAPITAL L P 05/13/2026 450.58 K $11.16 M   54.20% 0.37%
RENAISSANCE GROUP LLC 05/13/2026 445.22 K $11.02 M   28.54% 0.36%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 425.87 K $10.54 M   100.00% 0.35%
GABLES CAPITAL MANAGEMENT INC. 05/01/2026 424.58 K $10.51 M   -0.01% 0.35%
NUVEEN, LLC 04/30/2026 419.51 K $10.39 M   0.24% 0.34%

Catalyst Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 478 institutional investors and hedge funds held shares of Catalyst Pharmaceuticals Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 18.77 M

STATE STREET CORP: 6.86 M

AMERICAN CENTURY COMPANIES INC: 4.14 M

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 3.94 M

DIMENSIONAL FUND ADVISORS LP: 3.43 M

BANK OF AMERICA CORP /DE/: 3.04 M

85.52% of Catalyst Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 130.32 M shares in the last 24 months. This purchase volume represents approximately $3.23 B in transactions.